Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Table S1 from Phase II study of docetaxel and trametinib in patients with KRAS mutation positive recurrent non-small cell lung cancer (NSCLC) (SWOG S1507, NCT-02642042)
  1. Home
  2. Publications
  3. Supplementary Table S1 from Phase II study of docetaxel and trametinib in patients with KRAS mutation positive recurrent non-small cell lung cancer (NSCLC) (SWOG S1507, NCT-02642042)

Supplementary Table S1 from Phase II study of docetaxel and trametinib in patients with KRAS mutation positive recurrent non-small cell lung cancer (NSCLC) (SWOG S1507, NCT-02642042)

Authors:
  • SGShirish M. Gadgeel
    Shirish M. Gadgeel
  • JMJieling Miao
    Jieling Miao
  • JRJonathan W. Riess
    Jonathan W. Riess
  • JMJames Moon
    James Moon
  • PMPhilip C. Mack
    Philip C. Mack
  • GGGregory J. Gerstner
    Gregory J. Gerstner
  • TBTimothy F. Burns
    Timothy F. Burns
  • ATAsma Taj
    Asma Taj
  • WAWallace L. Akerley
    Wallace L. Akerley
  • KDKonstantin H. Dragnev
    Konstantin H. Dragnev
  • NLNoel Laudi
    Noel Laudi
  • MRMary W. Redman
    Mary W. Redman

Open Access
Publisher website
Google Scholar
  • 16 September 2024
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.27031963.v1
Abstract
Supplementary Table 1. Dose Modifications for Docetaxel and Trametinib
Keywords
  • CHEMOTHERAPY
  • CLINICAL TRIAL RESULTS
  • PHASE II CLINICAL TRIALS
  • DRUG TARGETS
  • ONCOPROTEIN & TUMOR SUPPRESSOR DRUG TARGETS
  • LUNG CANCER
  • SMALL MOLECULE AGENTS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.